Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVOCART 3D vs Microfracture for Knee Cartilage Defects
NCT01957722Phase 3Active, not recruiting
- Sponsor
- Aesculap Biologics
- Start
- Dec 2013
- Primary completion
- Dec 2025
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 3 trial of NOVOCART 3D in Articular cartilage defect, sponsored by Aesculap Biologics. Started Dec 2013; status: active, not recruiting.
02
Drugs
NOVOCART 3D
03
Conditions
Articular cartilage defect
Beyond the preview
Go deeper on NCT01957722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957722.